Hudson Bay Capital Management
CATX icon

Hudson Bay Capital Management’s Perspective Therapeutics CATX Stock Holding History

Hudson Bay Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96.3K Buy
+23,090
New +$97.6K ﹤0.01% 1184
2024
Q2 		– Sell
-85,000
Closed -$1.01M – 795
2024
Q1 		$1.01M Buy
+85,000
New +$725K 0.01% 541
2016
Q3 		– Sell
-1,020
Closed -$9K – 448
2016
Q2 		$9K Buy
+1,020
New +$9.76K ﹤0.01% 351

Other funds holding CATX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hudson Bay Capital Management's CATX Position: Q1 2026 in Review

Hudson Bay Capital Management opened a new position in Perspective Therapeutics (CATX) in Q1 2026: 23,090 shares worth $96.3K. The stake represents ﹤0.01% of the portfolio and ranks #1184 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in CATX as recently as Q1 2024.

Hudson Bay Capital Management first reported a position in CATX in Q2 2016 and has held it in 3 quarters since. The position peaked at $1.01M in Q1 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Hudson Bay Capital Management held 23,090 shares of Perspective Therapeutics worth $96.3K as of Q1 2026.
  • Perspective Therapeutics was a new Hudson Bay Capital Management position in Q1 2026.
  • Perspective Therapeutics made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1184 holding.
  • Hudson Bay Capital Management first reported a position in Perspective Therapeutics in Q2 2016 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Perspective Therapeutics position peaked at $1.01M in Q1 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.